Poor outcomes after acute myocardial infarction in systemic lupus erythematosus
- PMID: 19208594
- DOI: 10.3899/jrheum.080373
Poor outcomes after acute myocardial infarction in systemic lupus erythematosus
Abstract
Objective: Systemic lupus erythematosus (SLE) is associated with higher risk for acute myocardial infarction (MI); but the post-infarction outcomes among these patients are unknown. Our objective was to compare post-acute MI outcomes in patients with SLE to those with diabetes mellitus (DM) and those with neither condition.
Methods: We analyzed the risk for prolonged hospitalization and in-hospital mortality following acute MI in the 1993-2002 US Nationwide Inpatient Sample. We used logistic regression to calculate odds ratios (OR) for prolonged hospitalization and Cox proportional hazards regression to calculate hazard ratios (HR) for in-hospital mortality with and without adjustments for age, sex, race/ethnicity, socioeconomic status, and presence of congestive heart failure.
Results: For the SLE (n = 2192), DM (n = 236,016), SLE/DM (n = 474), and control (n = 667,956) groups, the in-hospital mortality rates were 8.3%, 6.2%, 5.7%, and 4.7%, respectively. In multivariable regression models, all 3 disease groups had higher adverse outcome risk compared to control. The OR for prolonged hospitalization was higher for those with SLE (OR 1.48, 95% CI 1.32-1.79) compared to those with DM (OR 1.30, 95% CI 1.28-1.32). A similar pattern was observed for hazard ratios for in-hospital mortality as well (SLE, HR 1.65, 95% CI 1.33-2.04; DM, HR 1.11, 95% CI 1.07-1.14).
Conclusion: SLE, like DM, increases risk of poor outcomes after acute MI. These patients need to be triaged appropriately for aggressive care.
Comment in
-
Cardiovascular outcomes in systemic lupus erythematosus: big studies for big questions.J Rheumatol. 2009 Mar;36(3):467-9. doi: 10.3899/jrheum.090015. J Rheumatol. 2009. PMID: 19286857 No abstract available.
Similar articles
-
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.Arthritis Rheumatol. 2017 Sep;69(9):1823-1831. doi: 10.1002/art.40174. Epub 2017 Aug 13. Arthritis Rheumatol. 2017. PMID: 28598016 Free PMC article.
-
Outcomes in hospitalized pediatric patients with systemic lupus erythematosus.Pediatrics. 2014 Jan;133(1):e106-13. doi: 10.1542/peds.2013-1640. Epub 2013 Dec 30. Pediatrics. 2014. PMID: 24379234 Free PMC article.
-
Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Rheumatology (Oxford). 2009 Jul;48(7):817-22. doi: 10.1093/rheumatology/kep102. Epub 2009 May 19. Rheumatology (Oxford). 2009. PMID: 19454606 Free PMC article.
-
Clinical Outcomes of Acute Myocardial Infarction Hospitalizations With Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database.Curr Probl Cardiol. 2022 Nov;47(11):101086. doi: 10.1016/j.cpcardiol.2021.101086. Epub 2021 Dec 20. Curr Probl Cardiol. 2022. PMID: 34936910 Review.
-
The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus.Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i67-i77. doi: 10.1093/rheumatology/kew399. Rheumatology (Oxford). 2017. PMID: 27940583 Review.
Cited by
-
Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician.Immunotargets Ther. 2023 Dec 8;12:175-186. doi: 10.2147/ITT.S377076. eCollection 2023. Immunotargets Ther. 2023. PMID: 38089168 Free PMC article. Review.
-
Cardiovascular disease in systemic lupus erythematosus.Rheumatol Immunol Res. 2021 Dec 15;2(3):157-172. doi: 10.2478/rir-2021-0022. eCollection 2021 Sep 1. Rheumatol Immunol Res. 2021. PMID: 35880242 Free PMC article. Review.
-
Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE.Lupus Sci Med. 2019 Jun 27;6(1):e000321. doi: 10.1136/lupus-2019-000321. eCollection 2019. Lupus Sci Med. 2019. PMID: 31321062 Free PMC article.
-
Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.Arthritis Res Ther. 2015 Feb 27;17(1):38. doi: 10.1186/s13075-015-0552-2. Arthritis Res Ther. 2015. PMID: 25879786 Free PMC article.
-
Atherosclerotic vascular disease in the autoimmune rheumatologic patient.Curr Atheroscler Rep. 2015 Apr;17(4):497. doi: 10.1007/s11883-015-0497-6. Curr Atheroscler Rep. 2015. PMID: 25721102 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical